Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
J Med Case Rep ; 18(1): 285, 2024 Jun 21.
Article in English | MEDLINE | ID: mdl-38902817

ABSTRACT

BACKGROUND: An aortoesophageal fistula can prove to be fatal. Salvage thoracic endovascular aortic repair as a bridging therapy and radical surgery with thoracotomy should be considered while treating aortoesophageal fistula without spontaneous closure. Moreover, it is essential to select a technique that reduces the risk of reinfection. Here we report a rare case of a ruptured thoracic aortic aneurysm related to esophageal perforation by a fish bone that led to massive hematemesis and shock, and the surgical treatment of an aortoesophageal fistula that developed after salvage thoracic endovascular aortic repair. CASE PRESENTATION: A 70-year-old Japanese female patient was admitted with hematemesis, thoracic pain, and shock related to esophageal perforation of a ruptured descending aortic aneurysm caused by fish bone aspiration and esophageal perforation 1 month previously. An emergency thoracic endovascular aortic repair was performed. Postoperatively, an aortoesophageal fistula that remained open and a food intake-related increase in the inflammatory response was noted. Radical blood-vessel prosthesis implantation and fistula closure were performed. The patient's postoperative course was favorable and the patient was discharged 22 days after the blood vessel prosthesis implantation. CONCLUSION: Such a case of rupture of a descending aortic aneurysm related to perforation by a fish bone and an aortoesophageal fistula is considerably rare. Thus, we report the therapeutic strategy of this particular case and review the relevant literature.


Subject(s)
Aortic Aneurysm, Thoracic , Aortic Rupture , Endovascular Procedures , Esophageal Fistula , Esophageal Perforation , Humans , Female , Esophageal Fistula/surgery , Esophageal Fistula/etiology , Aged , Endovascular Procedures/methods , Aortic Aneurysm, Thoracic/surgery , Aortic Rupture/surgery , Esophageal Perforation/surgery , Esophageal Perforation/etiology , Vascular Fistula/surgery , Vascular Fistula/etiology , Blood Vessel Prosthesis Implantation , Salvage Therapy/methods , Animals , Hematemesis/etiology , Aortic Diseases/surgery , Aortic Diseases/etiology , Aorta, Thoracic/surgery , Treatment Outcome , Fishes , Endovascular Aneurysm Repair
2.
Gan To Kagaku Ryoho ; 50(13): 1715-1717, 2023 Dec.
Article in Japanese | MEDLINE | ID: mdl-38303183

ABSTRACT

A 78-year-old woman underwent total gastrectomy with distal pancreatectomy and splenectomy for type 3 gastric cancer and a cystic tumor of the pancreas. Her pathological diagnosis was pT4aN3bM0, pStage ⅢC, and HER2-negative. Capecitabine and oxaliplatin was started as an adjuvant therapy, and capecitabine was administered until 1 year postoperatively. Thirteen months after surgery, she had a recurrence in S3 of the liver and underwent liver resection due to solitary metastasis. The postoperative diagnosis was peritoneal dissemination of gastric cancer with invasion of the falciform ligament. S-1 was started postoperatively. Ten months after surgery, she had a recurrence in S3 of the liver and underwent repeated resection. It invaded into the diaphragm and pericardium, and the final diagnosis was recurrent peritoneal dissemination of gastric cancer. After 5 courses of paclitaxel and ramucirumab, nivolumab was started as a fourth-line therapy for the recurrence of the right supraclavicular lymph nodes, bone, and liver. She had some immune-related adverse events(irAE), including hypothyroidism and hypoadrenocorticism, which required management, but she maintained PR more than 2 years after the initiation of the treatment. Multimodality therapies, including repeated resection and nivolumab, were considered to help her long-term survival.


Subject(s)
Nivolumab , Stomach Neoplasms , Humans , Female , Aged , Nivolumab/therapeutic use , Stomach Neoplasms/drug therapy , Stomach Neoplasms/surgery , Capecitabine/therapeutic use , Lymph Nodes/pathology , Ramucirumab , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Gastrectomy
SELECTION OF CITATIONS
SEARCH DETAIL
...